Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV.

Saved in:
Bibliographic Details
Title: Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV.
Authors: Chalouni M; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA., Torgersen J; Department of Medicine, Perelman School of Medicine.; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rentsch CT; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Van Santen DK; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA., Jarrin I; Hospital General Universitario Gregorio Marañón, liSGM, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Young J; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Gill MJ; Southern Alberta Clinic and Department of Medicine, University of Calgary, Calgary, AB, Canada., Epstein RL; Department of Medicine, Section of Infectious Diseases, Boston Medical Center.; Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Linas B; Department of Medicine, Section of Infectious Diseases, Boston Medical Center.; Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Zangerle R; Department of Dermatology, Venereology, and Allergy, Medical University Innsbruck, Innsbruck, Austria., Surial B; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern., Nemeth J; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Touloumi G; Department of Hygiene, Epidemiology, & Medical Statistics., Papadopoulos A; 4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece., Wittkop L; University of Bordeaux, INSERM, Bordeaux Population Health-U1219, CIC1401-EC, Bordeaux, France; SISTM, INRIA, Talence, France; CHU de Bordeaux, Bordeaux University Hospital, Service d'information médicale, INSERM, Bordeaux, France., Van Der Valk M; Stichting hiv Monitoring.; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases and Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Boyd A; Stichting hiv Monitoring.; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases and Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Monforte AD; Icona Foundation, Milan, Italy., Puoti M; Icona Foundation, Milan, Italy., Logan RW; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA., Rein SM; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA., Miro JM; Infectious Diseases Service, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain; Reial Academia de Medicina de Catalunya (RAMC), Barcelona, Spain., Berenguer J; Hospital General Universitario Gregorio Marañón, liSGM, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Hernán MA; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA.; Department of Biostatistics, Harvard T H Chan School of Public Health, Harvard University., Lodi S; CAUSALab, Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA.; Boston University School of Public Health, Boston, MA, USA.
Source: AIDS (London, England) [AIDS] 2026 Aug 01; Vol. 40 (8), pp. 1073-1081. Date of Electronic Publication: 2026 Mar 24.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5571
DOI:10.1097/QAD.0000000000004499